Expert Ali Meli explains why investors short Oracle as a 'cheap proxy' to hedge AI credit risk, citing OpenAI exposure and ...
Though it certainly doesn’t feel like it, Oracle (NASDAQ:ORCL) shares finished 2025 with respectable, market-beating gains ...
Oracle and Palantir took center stage this year as the artificial intelligence sector continued to dominate the conversation.
Oracle expects its revenue to explode from $67 billion in fiscal 2026 to $225 billion in fiscal 2030 as the company rapidly ...
Oracle has gone from market darling to market riddle in a matter of months, with a brutal sell‑off colliding head‑on with one ...
Tumor-infiltrating microorganisms have been presented as an unappreciated component of the tumor microenvironment, but there are few examples of their influence on tumor phenotypes or response to ...
A representation of ultrawideband PVDF/co-polymer-based ultrasound (US) transducer technology for high-frequency hemispherical optoacoustic tomography and its potential use in hand vascular, dental, ...